China's NAFMII Accepts Fosun Pharma's Application to Issue Up to 10 Billion Yuan Bonds

MT Newswires Live03-26

China's National Association of Financial Market Institutional Investors accepted the application of Shanghai Fosun Pharmaceutical (Group) (HKG:2196, SHA:600196) to issue bonds of up to 10 billion yuan, according to a Hong Kong Stock Exchange filing on Tuesday.

The bonds are medium-term bonds worth 4 billion yuan and super short-term bonds amounting to 6 billion yuan.

The issuance of both bonds is valid within two years. Bank of Shanghai (SHA:601229) and China Merchants Bank (HKG:3968, SHA:600036) will serve as the joint lead underwriters for the issuances, the pharmaceutical company said.

The company's Hong Kong shares fell less than 2% in recent trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment